Among them, M8 elicited a stronger antiviral response both in vitro and in vivo, inhibiting viral infections in primary human DCs and prolonging survival and reducing viral loads in mice challenged with influenza and chikungunya viruses (Beljanski et al., 2015; Chiang et al., 2015). The gene discussed is PRNT; the disease is viral infectious disease.